HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006.

We performed HIV-1 drug resistance genotypic analysis of viral isolates from 100 antiretroviral (ARV)-naive, recently HIV-1-infected (between 2002 and 2006) individuals from Abidjan (Côte d'Ivoire). The overall prevalence of HIV-1 variants with resistance mutations to reverse transcriptase, protease, or fusion inhibitors was 6%. The majority of isolates were CRF02_AG. Compared with a previous study carried out by our group in 2001-2002 in a similar population in Abidjan, our findings confirm the circulation and transmission of HIV-1 carrying key ARV drug resistance mutation.

[1]  H. Kräusslich,et al.  Analysis of the diversity of the HIV‐1 pol gene and drug resistance associated changes among drug‐naïve patients in Burkina Faso , 2009, Journal of medical virology.

[2]  E. Magiorkinis,et al.  Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications. , 2009 .

[3]  S. Frost,et al.  Sexual networks and the transmission of drug-resistant HIV , 2008, Current opinion in infectious diseases.

[4]  H. Kräusslich,et al.  HIV Drug Resistance Pattern Among HAART-Exposed Patients With Suboptimal Virological Response in Ouagadougou, Burkina Faso , 2008, Journal of acquired immune deficiency syndromes.

[5]  J. Ellner,et al.  Drug‐resistant TB and HIV in resource‐limited settings: what TB/HIV programmes can learn from each other , 2008, Tropical medicine & international health : TM & IH.

[6]  S. Hammer,et al.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Salamon,et al.  Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire. , 2007, Bulletin of the World Health Organization.

[8]  John Nkengasong,et al.  Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa. , 2005, AIDS research and human retroviruses.

[9]  F. Dabis,et al.  Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission , 2005, AIDS.

[10]  R. Salamon,et al.  Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. , 2003, AIDS research and human retroviruses.

[11]  Victoria A Johnson,et al.  Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Salamon,et al.  Clinical and Biological Evolution of HIV‐1 Seroconverters in Abidjan, Côte d’Ivoire, 1997‐2000 , 2002, Journal of acquired immune deficiency syndromes.

[13]  K. Hertogs,et al.  High Prevalence of Genotypic and Phenotypic HIV‐1 Drug‐Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'lvoire , 2001, Journal of Acquired Immune Deficiency Syndromes.

[14]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.